Key result
Cardiac resynchronization therapy improved LVEF from 26.8% to 29.1%, and Gated SPECT LV phase analysis parameters predicted CRT non-response.
Why the study?
Does Gated SPECT LV phase analysis predict response to cardiac resynchronization therapy in patients undergoing CRT implantation?
Observational (n=30)
Does Gated SPECT LV phase analysis predict response to cardiac resynchronization therapy in patients undergoing CRT implantation?
Answers are grounded in this paper and cite their sources.
Gated SPECT LV phase analysis can identify baseline dyssynchrony parameters that predict echocardiographic response and reverse remodeling following cardiac resynchronization therapy.
Background: Left ventricular dyssynchrony plays an important role in predicting response to cardiac resynchronization therapy (CRT). Methods: Thirty patients underwent CRT implantation. Assessment of left ventricular (LV) dyssynchrony was done through Gated SPECT LV phase analysis. Results: Thirty patients received CRT (mean age 58.7 ± 9.0, 24 males). CRT implantation had a favorable prognosis on cardiac functions (LVEF preimplantation: 26.8 ± 4.7% versus 29.1 ± 6.4% post-implantation; P = 0.002). Reverse LV remodeling (⩾15%) was documented in 19 patients. Temporal changes in LV dyssynchrony parameters were correlated to LV reverse remodeling. Applying ROC curve for LV phase analysis showed that a cutoff value of 152° for histogram bandwidth had a sensitivity of 72.7% and specificity of 63.2% for predicting CRT non-response status. Also, a cutoff value of 54° for histogram standard deviation had a sensitivity of 81.8% and specificity of 63.2%. Conclusion: Responders of CRT showed improved LV dyssynchrony profiles. Utilizing Gated SPECT LV analysis could provide predictors for CRT non-response. Reverse LV remodeling is associated with temporal improvements in LV dyssynchrony parameters.
No takes yet. Share an insight, caveat, or question.
Ahmed et al. (2016) conducted an observational in Heart failure requiring cardiac resynchronization therapy (n=30). Cardiac resynchronization therapy (CRT) vs. Pre-implantation (baseline) was evaluated on Left ventricular ejection fraction (LVEF) (p=0.002). Cardiac resynchronization therapy improved LVEF from 26.8% to 29.1%, and Gated SPECT LV phase analysis parameters predicted CRT non-response.
Synapse has enriched 10 related papers. Consider them for comparative context: